Zepbound

Topic

Zepbound is a brand name for tirzepatide, an anti-obesity medication used for chronic weight management and the treatment of obstructive sleep apnea in adults. It functions as a dual gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Developed by Eli Lilly and Company, the drug is administered via weekly subcutaneous injections.